Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gowthami M Arepally

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 23, 2022
Minimal role for the alternative pathway in complement activation by HIT immune complexesAyiesha P Barnes, Sanjay Khandelwal, Simone Sartoretto, et al.
Blood|November 30, 2023
Deciphering and disrupting PIEZO1-TMEM16F interplay in hereditary xerocytosisPengfei Liang, Yang Zhang, Yui Chun S Wan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 27, 2023
Inhibition of the C1s Protease and the Classical Complement Pathway by 6-(4-Phenylpiperazin-1-yl)Pyridine-3-Carboximidamide and Chemical AnalogsXin Xu, Timothy J Herdendorf, Huiquan Duan, et al.
Blood|March 1, 2013
Novel diagnostic assays for heparin-induced thrombocytopeniaAdam Cuker, Ann H Rux, Jillian L Hinds, et al.
Blood Advances|November 29, 2018
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopeniaAdam Cuker, Gowthami M Arepally, Beng H Chong, et al.
Blood|June 30, 2021
Complement mediates binding and procoagulant effects of ultralarge HIT immune complexesSanjay Khandelwal, Ayiesha Barnes, Lubica Rauova, et al.
Research and Practice in Thrombosis and Haemostasis|May 3, 2024
Coagulation and platelet biology at the intersection of health and disease: illustrated capsules of the 11th Symposium on Hemostasis at the University of North CarolinaMaria Aleman, Gowthami M Arepally, Trevor Baglin, et al.
Nature Communications|September 16, 2021
C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primatesRobin Schmitz, Zachary W Fitch, Paul M Schroder, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Blood|June 30, 2026
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Journal of Thrombosis and Haemostasis : JTH|August 23, 2022
Minimal role for the alternative pathway in complement activation by HIT immune complexesAyiesha P Barnes, Sanjay Khandelwal, Simone Sartoretto, et al.
Blood|November 30, 2023
Deciphering and disrupting PIEZO1-TMEM16F interplay in hereditary xerocytosisPengfei Liang, Yang Zhang, Yui Chun S Wan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 27, 2023
Inhibition of the C1s Protease and the Classical Complement Pathway by 6-(4-Phenylpiperazin-1-yl)Pyridine-3-Carboximidamide and Chemical AnalogsXin Xu, Timothy J Herdendorf, Huiquan Duan, et al.
Blood|March 1, 2013
Novel diagnostic assays for heparin-induced thrombocytopeniaAdam Cuker, Ann H Rux, Jillian L Hinds, et al.
Blood Advances|November 29, 2018
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopeniaAdam Cuker, Gowthami M Arepally, Beng H Chong, et al.
Blood|June 30, 2021
Complement mediates binding and procoagulant effects of ultralarge HIT immune complexesSanjay Khandelwal, Ayiesha Barnes, Lubica Rauova, et al.
Research and Practice in Thrombosis and Haemostasis|May 3, 2024
Coagulation and platelet biology at the intersection of health and disease: illustrated capsules of the 11th Symposium on Hemostasis at the University of North CarolinaMaria Aleman, Gowthami M Arepally, Trevor Baglin, et al.
Nature Communications|September 16, 2021
C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primatesRobin Schmitz, Zachary W Fitch, Paul M Schroder, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Blood|June 30, 2026
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Pageof 8